BWXT Awarded Contract to Produce High Purity Depleted Uranium for National Defense Purposes
(LYNCHBURG, Va. – Sept. 30, 2025) BWX Technologies, Inc. (NYSE: BWXT) announced today it has been awarded a 10-year contract valued at $1.6 billion by the Department of Energy’s National Nuclear Security Administration to support the national security mission of establishing a supply of high purity depleted uranium (HPDU).
BWXT Announces $2.6 billion in Contracts for Naval Nuclear Reactor Components
(LYNCHBURG, Va. – July 17, 2025) BWX Technologies, Inc. (NYSE: BWXT) announced today the award of U.S. Naval Nuclear Propulsion Program contracts totaling approximately $2.6 billion, including future year options, for manufacturing naval nuclear reactor components. The contracts primarily support Virginia and Columbia-class submarines as well as some work for certain Ford-class aircraft carrier components. Products contracted with these awards will be delivered during the next six to eight years.
BWXT-Led Team Awarded Canadian Nuclear Laboratories Contract from Atomic Energy of Canada Limited
(Lynchburg, Va. – June 12, 2025) – BWX Technologies, Inc. (NYSE: BWXT) announced today an Atomic Energy of Canada Limited award for the management and operation of Canadian Nuclear Laboratories Ltd. (CNL).
BWXT Joint Venture Awarded Strategic Petroleum Reserve Contract
(LYNCHBURG, Va. – April 9, 2025) – BWX Technologies, Inc. (NYSE: BWXT) announced today a U.S. Department of Energy award to manage and operate the Strategic Petroleum Reserve.
BWXT Announces $2.1 Billion in Contracts for Naval Nuclear Reactor Components
(LYNCHBURG, Va. – Feb. 19, 2025) – BWX Technologies, Inc. (NYSE: BWXT) today announced the award of U.S. Naval Nuclear Propulsion Program contracts totaling approximately $2.1 billion for the manufacture of reactor components. Naval nuclear reactor component manufacturing and material procurement activities for Columbia and Virginia class submarines, as well as Ford class aircraft carriers, […]
BWXT-Led Team Awarded $3 Billion Cleanup Contract for Department of Energy’s West Valley Demonstration Project
(LYNCHBURG, Va. – December 2, 2024) – BWX Technologies, Inc. (NYSE: BWXT) is pleased to announce an award from the U.S. Department of Energy for cleanup operations at the West Valley Demonstration Project in West Valley, New York. The Phase 1B contract was awarded to West Valley Cleanup Alliance, LLC (WVCA), which is a joint […]
Hanford Tank Waste Operations & Closure, LLC Approved to Begin Hanford Tanks Cleanup Contract
(LYNCHBURG, Va. – October 17, 2024) – BWX Technologies, Inc. (NYSE: BWXT) is pleased to announce that Hanford Tank Waste Operations & Closure, LLC (H2C) has been approved by the U.S. Department of Energy (DOE) to begin the Hanford Integrated Tank Disposition Contract (ITDC). After being previously approved to work on pre-transition activities, the DOE […]
BWXT selected for nuclear fuel deconversion award by U.S. Department of Energy
(LYNCHBURG, Va. – Oct. 8, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its Nuclear Fuel Services, Inc. (NFS) subsidiary was selected by the U.S. Department of Energy (DOE) as one of the successful bidders for High-Assay Low-Enriched Uranium (HALEU) deconversion services to support the civil advanced reactor marketplace. This is an indefinite-delivery, […]
BWXT Awarded Contract to Develop Pilot Plant Solution for Domestic Uranium Enrichment
(LYNCHBURG, Va. – August 26, 2024) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from the National Nuclear Security Administration (NNSA) to complete a yearlong engineering study to evaluate options for the deployment of a centrifuge pilot plant that would establish a domestic uranium enrichment capability for national security purposes. Awarded to BWXT […]
BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production
(OTTAWA, Ontario and Beloit, WI – July 22, 2024) – BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) today announced that they have signed a Master Services Agreement (MSA), which will facilitate the production of actinium-225 (Ac-225), a critical medical isotope used to kill cancer cells […]